Source: International Congress 2017 – The acute patient: the clinical point-of-view
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Martynyuk (Moscow, Switzerland). The influence of trimetazidine (Tmz) on quality of life in patients with IPAH. 4739

Member's Comments

No comment yet.

Related content which might interest you: The influence of fenspiride in complex therapy on quality of life in COPD patients Source: Annual Congress 2010 - COPD: management Year: 2010 NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial Source: Annual Congress 2011 - Bronchodilators in asthma and COPD Year: 2011 Indacaterol once-daily improves health-related quality of life (HRQOL) in COPD patients: a 52-week study Source: Annual Congress 2009 - New bronchodilators Year: 2009 Influence of tiotropium bromide (TB) on the severity of clinical, functional symptoms and health-related quality of life (HRQL) in COPD patients (pts) Source: Annual Congress 2011 - COPD management Year: 2011 Budesonide/formoterol adjustable maintenance dosing (AMD) improves health-related quality of life (HRQL) compared with high-dose budesonide (AMD) Source: Eur Respir J 2004; 24: Suppl. 48, 311s Year: 2004 Evaluation of quality of life (QOL) in asthma patients during 6 months formoterol therapy Source: Eur Respir J 2001; 18: Suppl. 33, 44s Year: 2001 Tiotropium + olodaterol fixed-dose combination shows clinically meaningful improvements in quality of life versus placebo Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis Year: 2015 Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients Source: Eur Respir J 2005; 26: Suppl. 49, 563s Year: 2005 Health-related quality of life (HRQL) and use of formoterol in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 55s Year: 2001 Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium Source: Annual Congress 2009 - New bronchodilators Year: 2009 Quality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1) Source: Eur Respir J 2010; 35: 118-123 Year: 2010 Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 NIPPV‘s influence in severe COPD patients health-related quality of life Source: Eur Respir J 2006; 28: Suppl. 50, 186s Year: 2006 Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009 Health-related quality of life (HRQL) and patient-reported outcomes (PRO) in COPD patients receiving add-on-therapy with EPs® 7630 Source: Annual Congress 2011 - COPD management Year: 2011 Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013 Group therapy as a technique to improve quality of life in asthmatic patients Source: Eur Respir J 2006; 28: Suppl. 50, 843s Year: 2006 Patients with COPD using salmeterol/fluticasone propionate combination therapy experience improved quality of life Source: Eur Respir J 2003; 22: Suppl. 45, 51s Year: 2003 Does rehabilitation improve health-related quality of life (HRQL) in patients with advanced respiratory failure? Source: Annual Congress 2007 - Health-related quality of life (HRQL) in patients with severe chronic respiratory failure Year: 2007 Subtle assessment of quality of life in PH patients on inhaled iloprost treatment Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012